Onco Therapies, a division of Agila, which is a wholly owned subsidiary of Strides Arcolab, has received European approval for its Oral Dosage Oncology facility (tablet and hard gelatine capsules) in Bangalore. The injectable facility within the Oncology complex has already been approved by all major regulatory agencies. Thus, the facility is now amongst a few European approved Oral Dosage oncology plants worldwide.
Further, the company expects to commercialize 2 products in Europe during Q3 2011. The state of art Oncology complex which was established in 2009 manufactures injectables, oral products (tablets and soft gels) in the oncology domain. It has been built to the most exacting standards, meeting the requirements of the regulatory authorities in the most stringent global markets and is already approved by all the major regulatory authorities following the company to sell off globally.
Agila is the specialties unit of Strides Arcolab which was spun off as a separate division post the company’s restricting in 2009. It is focused on key domains such as oncologyistics, penems, pencillins, cephalosphrins, opthalmics, peptides and biosimilars and operates from 8 world class global manufacturing facilities, including one of the largest steriles capacity in India and amongst the largest lyophilizations capacities in the world.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1808.50 |
Dr. Reddys Lab | 1342.45 |
Cipla | 1472.45 |
Lupin | 2147.55 |
Zydus Lifesciences | 973.90 |
View more.. |